• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非犹太型泰-萨克斯病中常见的一种突变:频率及RNA研究

A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies.

作者信息

Akerman B R, Zielenski J, Triggs-Raine B L, Prence E M, Natowicz M R, Lim-Steele J S, Kaback M M, Mules E H, Thomas G H, Clarke J T

机构信息

McGill University-Montreal Children's Hospital Research Institute, Quebec, Canada.

出版信息

Hum Mutat. 1992;1(4):303-9. doi: 10.1002/humu.1380010407.

DOI:10.1002/humu.1380010407
PMID:1301938
Abstract

Tay-Sachs disease (TSD) is an autosomal recessive genetic disorder resulting from mutation of the HEXA gene encoding the alpha-subunit of the lysosomal enzyme, beta-N-acetylhexosaminidase A (Hex A). We have discovered that a Tay-Sachs mutation, IVS-9 + 1 G-->A, first detected by Akli et al. (Genomics 11:124-134, 1991), is a common disease allele in non-Jewish Caucasians (10/58 alleles examined). A PCR-based diagnostic test, which detects an NlaIII site generated by the mutation, revealed a frequency among enzyme-defined carriers of 9/64 (14%). Most of those carrying the allele trace their origins to the United Kingdom, Ireland, or Western Europe. It was not identified among 12 Black American TSD alleles or in any of 18 Ashkenazi Jewish, enzyme-defined carriers who did not carry any of the mutations common to this population. No normally spliced RNA was detected in PCR products generated from reverse transcription of RNA carrying the IVS-9 mutation. Instead, the low levels of mRNA from this allele were comprised of aberrant species resulting from the use of either of two cryptic donor sites, one truncating exon 9 and the other within IVS-9, spliced to exon 10. Numerous additional splice products were detected, most involving skipping of one or more surrounding exons. Together with a recently identified allele responsible for Hex A pseudodeficiency (Triggs-Raine et al. Am J Hum Genet, 1992), these two alleles accounted for almost 50% (29/64) of TSD or carrier alleles ascertained by enzyme screening tests in non-Jewish Caucasians.

摘要

泰-萨克斯病(TSD)是一种常染色体隐性遗传病,由编码溶酶体酶β-N-乙酰己糖胺酶A(Hex A)α亚基的HEXA基因突变引起。我们发现,Akli等人(《基因组学》11:124 - 134,1991年)首次检测到的泰-萨克斯突变IVS-9 + 1 G→A,是在非犹太白种人中常见的致病等位基因(检测的58个等位基因中有10个)。一种基于聚合酶链反应(PCR)的诊断测试,可检测由该突变产生的NlaIII位点,结果显示在酶学定义的携带者中该突变频率为9/64(14%)。大多数携带该等位基因的人祖籍是英国、爱尔兰或西欧。在12个美国黑人TSD等位基因中未发现该突变,在18个未携带该人群常见突变的阿什肯纳兹犹太酶学定义携带者中也未发现。在携带IVS-9突变的RNA逆转录产生的PCR产物中未检测到正常剪接的RNA。相反,该等位基因的低水平信使核糖核酸(mRNA)由异常种类组成,这些异常种类是由于使用了两个隐蔽供体位点之一产生的,一个使外显子9截短,另一个在IVS-9内,与外显子10拼接。还检测到许多其他剪接产物,大多数涉及一个或多个周围外显子的跳跃。与最近发现的导致Hex A假缺陷的一个等位基因(Triggs-Raine等人,《美国人类遗传学杂志》,1992年)一起,这两个等位基因在非犹太白种人中通过酶筛选测试确定的TSD或携带者等位基因中占近50%(29/64)。

相似文献

1
A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies.非犹太型泰-萨克斯病中常见的一种突变:频率及RNA研究
Hum Mutat. 1992;1(4):303-9. doi: 10.1002/humu.1380010407.
2
Molecular basis of hexosaminidase A deficiency and pseudodeficiency in the Berks County Pennsylvania Dutch.宾夕法尼亚州伯克郡德裔宾夕法尼亚人中己糖胺酶A缺乏和假缺乏的分子基础。
Hum Mutat. 1992;1(4):298-302. doi: 10.1002/humu.1380010406.
3
Identification of an altered splice site in Ashkenazi Tay-Sachs disease.在阿什肯纳齐家族性黑蒙性痴呆症中鉴定出一个改变的剪接位点。
Nature. 1988 May 5;333(6168):85-6. doi: 10.1038/333085a0.
4
Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.己糖胺酶A基因中导致泰-萨克斯病的突变和中性多态性。
Hum Mutat. 1997;9(3):195-208. doi: 10.1002/(SICI)1098-1004(1997)9:3<195::AID-HUMU1>3.0.CO;2-7.
5
A chronic GM2 gangliosidosis variant with a HEXA splicing defect: quantitation of HEXA mRNAs in normal and mutant fibroblasts.一种具有己糖胺酶A(HEXA)剪接缺陷的慢性GM2神经节苷脂贮积症变异型:正常和突变成纤维细胞中HEXA mRNA的定量分析
Eur J Hum Genet. 1997 May-Jun;5(3):129-36.
6
An unusual genotype in an Ashkenazi Jewish patient with Tay-Sachs disease.一名患有泰-萨克斯病的阿什肯纳兹犹太患者的罕见基因型。
Hum Mutat. 1992;1(6):486-90. doi: 10.1002/humu.1380010606.
7
Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.常见的己糖胺酶B基因多态性会降低血清中己糖胺酶A和己糖胺酶B的酶活性,这可能会掩盖对泰-萨克斯病携带者的识别。
Mol Genet Metab. 2006 Feb;87(2):122-7. doi: 10.1016/j.ymgme.2005.10.012. Epub 2005 Dec 13.
8
Tay-Sachs disease and HEXA mutations among Moroccan Jews.摩洛哥犹太人中的泰-萨克斯病与HEXA突变
Hum Mutat. 1997;10(4):295-300. doi: 10.1002/(SICI)1098-1004(1997)10:4<295::AID-HUMU5>3.0.CO;2-G.
9
Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests.对阿什肯纳兹犹太人进行泰-萨克斯病携带者筛查。基于DNA检测和基于酶检测的比较。
N Engl J Med. 1990 Jul 5;323(1):6-12. doi: 10.1056/NEJM199007053230102.
10
Novel Tay-Sachs disease mutations from China.来自中国的新型泰-萨克斯病突变。
Hum Mutat. 1992;1(1):40-6. doi: 10.1002/humu.1380010107.

引用本文的文献

1
Advances in Diagnosis, Pathological Mechanisms, Clinical Impact, and Future Therapeutic Perspectives in Tay-Sachs Disease.泰-萨克斯病的诊断进展、病理机制、临床影响及未来治疗前景
Neurol Int. 2025 Jun 25;17(7):98. doi: 10.3390/neurolint17070098.
2
Late-Onset Tay-Sachs Disease in an Irish Family.一个爱尔兰家庭中的迟发性泰-萨克斯病
Mov Disord Clin Pract. 2020 Oct 28;8(1):106-110. doi: 10.1002/mdc3.13096. eCollection 2021 Jan.
3
Chaperone therapy for GM2 gangliosidosis: effects of pyrimethamine on β-hexosaminidase activity in Sandhoff fibroblasts.
GM2神经节苷脂贮积症的伴侣蛋白疗法:乙胺嘧啶对桑德霍夫成纤维细胞中β-己糖胺酶活性的影响
Mol Neurobiol. 2014 Aug;50(1):159-67. doi: 10.1007/s12035-013-8605-5. Epub 2013 Dec 20.
4
Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis.乙胺嘧啶作为晚发型GM2神经节苷脂沉积症的潜在药理伴侣分子。
J Biol Chem. 2007 Mar 23;282(12):9150-61. doi: 10.1074/jbc.M609304200. Epub 2007 Jan 21.
5
Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.人β-己糖胺酶B的晶体结构:理解桑德霍夫病和泰-萨克斯病的分子基础
J Mol Biol. 2003 Apr 11;327(5):1093-109. doi: 10.1016/s0022-2836(03)00216-x.
6
Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.非犹太裔泰-萨克斯病携带者中的新型突变及基于DNA的筛查
Am J Hum Genet. 1997 May;60(5):1099-106.
7
Heterozygosity for Tay-Sachs disease in non-Jewish Americans with ancestry from Ireland or Great Britain.有爱尔兰或英国血统的非犹太裔美国人中泰-萨克斯病的杂合子情况。
J Med Genet. 1996 Oct;33(10):829-32. doi: 10.1136/jmg.33.10.829.
8
Further investigation of the HEXA gene intron 9 donor splice site mutation frequently found in non-Jewish Tay-Sachs disease patients from the British Isles.对在来自不列颠群岛的非犹太型泰-萨克斯病患者中频繁发现的HEXA基因内含子9供体剪接位点突变进行进一步研究。
J Med Genet. 1993 Jun;30(6):479-81. doi: 10.1136/jmg.30.6.479.
9
Molecular characterization of both alleles in an unusual Tay-Sachs disease B1 variant.一种罕见的泰-萨克斯病B1变异体中两个等位基因的分子特征分析。
Am J Hum Genet. 1994 Jun;54(6):1126-7.
10
A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: identification and frequency estimation.与明显的β-己糖胺酶A假性缺乏相关的第二种突变:鉴定与频率估计
Am J Hum Genet. 1993 Dec;53(6):1198-205.